Physician profile
Michael C Hardacre
NPI 1730171661
$850.11
in general payments reported to CMS, 2019-2025
14 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.05 · 2020: $30.06 · 2021: $246 · 2022: $51.92 · 2023: $149 · 2024: $207 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $501.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $178.47 | 2021-2024 | Spaceoar Vue System - 10ml |
| Progenics Pharmaceuticals, INC. | $118.42 | 2023 | Pylarify |
| Myovant Sciences INC. | $110.38 | 2021 | |
| Sobi, INC | $64.64 | 2023-2024 | |
| Reflexion Medical, INC. | $60.85 | 2021 | |
| Janssen Biotech, INC. | $59.25 | 2025 | Carvykti, Erleada, Balversa |
| Siemens Medical Solutions USA, INC. | $52.24 | 2021-2024 | Varian Ethos Treatment Planning |
| Varian Medical Systems, INC. | $51.11 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $39.96 | 2025 | Libtayo |
| Elekta, INC. | $30.16 | 2022 | |
| Novartis Pharmaceuticals Corporation | $26.32 | 2025 | |
| Accuray Incorporated | $21.76 | 2022 | |
| Bioprotect Medical, INC. | $19.22 | 2025 | Bioprotect Balloon Implant System |
| Zap Surgical Systems, INC. | $17.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hardacre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.